US Stock MarketDetailed Quotes

Ocular Therapeutix (OCUL)

Watchlist
  • 8.625
  • +0.120+1.41%
Trading Jul 27 15:02 ET
1.89BMarket Cap-5.99P/E (TTM)

Ocular Therapeutix (OCUL) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
2021/Q2
Total Revenue as Reported
+0.81%10.79M
-22.43%13.25M
-5.71%14.54M
-18.14%13.46M
-27.59%10.70M
+15.41%17.08M
+2.28%15.43M
+8.26%16.44M
+10.47%14.77M
+5.16%14.80M
+26.04%15.08M
+23.81%15.19M
+1.42%13.37M
+14.36%14.08M
-1.55%11.97M
+4.68%12.27M
+79.61%13.19M
+67.48%12.31M
+106.82%12.15M
+646.85%11.72M
Total Operating Revenue
+0.81%10.79M
-22.43%13.25M
-5.71%14.54M
-18.14%13.46M
-27.59%10.70M
+15.41%17.08M
+2.28%15.43M
+8.26%16.44M
+10.47%14.77M
+5.16%14.80M
+26.04%15.08M
+23.81%15.19M
+1.42%13.37M
+14.36%14.08M
-1.55%11.97M
+4.68%12.27M
+79.61%13.19M
+67.48%12.31M
+106.82%12.15M
+646.85%11.72M
Cost of Revenue
+5.31%1.33M
+29.59%1.59M
+13.65%1.77M
+28.83%1.94M
-4.83%1.26M
-11.26%1.23M
+13.36%1.56M
+15.72%1.51M
+9.23%1.33M
+36.96%1.39M
+28.33%1.38M
+12.90%1.30M
-6.62%1.21M
-8.66%1.01M
-18.09%1.07M
+5.38%1.16M
+45.74%1.30M
+62.94%1.11M
+191.11%1.31M
+717.91%1.10M
Gross Profit
+0.21%9.46M
-26.47%11.66M
-7.89%12.77M
-22.88%11.52M
-29.83%9.44M
+18.17%15.85M
+1.17%13.86M
+7.56%14.93M
+10.59%13.45M
+2.69%13.42M
+25.82%13.70M
+24.94%13.88M
+2.30%12.16M
+16.63%13.06M
+0.45%10.89M
+4.60%11.11M
+84.29%11.89M
+67.94%11.20M
+99.83%10.84M
+640.21%10.62M
Operating Expense
+40.14%102.80M
+22.56%81.42M
+36.09%81.47M
+35.26%79.16M
+62.77%73.35M
+98.50%66.43M
+81.85%59.86M
+69.87%58.52M
+29.84%45.07M
+3.21%33.47M
+1.49%32.92M
+11.04%34.45M
+16.79%34.71M
+10.86%32.42M
+6.80%32.44M
+0.56%31.03M
+11.40%29.72M
+39.20%29.25M
+56.30%30.37M
+59.70%30.85M
Selling and Admin Expenses
+19.96%36.58M
+20.35%30.62M
+27.63%29.11M
-5.36%28.08M
+25.34%30.50M
+47.30%25.44M
+27.43%22.81M
+53.24%29.67M
+21.88%24.33M
-8.53%17.27M
-4.37%17.90M
+7.98%19.36M
+20.11%19.96M
+13.26%18.88M
+6.03%18.72M
+5.49%17.93M
+5.52%16.62M
+24.52%16.67M
+41.44%17.65M
+50.42%16.99M
-Selling & Marketing Expense
+17.17%16.58M
+23.58%1.63M
+14.95%1.44M
+18.86%1.52M
+1016.65%14.15M
+15.50%1.32M
+23.98%1.25M
-13.65%1.28M
+5.94%1.27M
+104.53%1.14M
-90.09%1.01M
-85.40%1.48M
-86.80%1.20M
-376.09%-25.22M
+6.37%10.19M
+20.84%10.14M
+12.08%9.06M
+34.14%9.14M
+46.87%9.58M
+36.37%8.39M
-General & Admin Expense
+22.38%20.01M
+20.17%28.99M
+28.37%27.67M
-6.45%26.56M
-29.12%16.35M
+49.55%24.12M
+27.63%21.56M
+58.78%28.39M
+22.90%23.06M
-63.43%16.13M
+97.98%16.89M
+129.59%17.88M
+148.33%18.77M
+485.34%44.11M
+5.62%8.53M
-9.49%7.79M
-1.41%7.56M
+14.57%7.54M
+35.50%8.08M
+67.21%8.60M
Research & Development
+54.50%66.21M
+23.94%50.80M
+41.30%52.36M
+77.01%51.08M
+106.69%42.86M
+153.10%40.99M
+146.71%37.05M
+91.18%28.86M
+40.60%20.74M
+19.58%16.20M
+9.48%15.02M
+15.22%15.09M
+12.57%14.75M
+7.67%13.54M
+7.86%13.72M
-5.48%13.10M
+19.89%13.10M
+64.98%12.58M
+82.98%12.72M
+72.78%13.86M
Operating Profit
-46.03%-93.34M
-37.93%-69.76M
-49.35%-68.70M
-55.18%-67.64M
-102.16%-63.92M
-152.25%-50.58M
-139.40%-46.00M
-111.91%-43.59M
-40.21%-31.62M
-3.56%-20.05M
+10.82%-19.21M
-3.28%-20.57M
-26.45%-22.55M
-7.27%-19.36M
-10.32%-21.54M
+1.56%-19.92M
+11.84%-17.83M
-25.84%-18.05M
-39.43%-19.53M
-13.12%-20.23M
Net Non-Operating Interest Income (Expense)
+288.72%3.27M
+188.24%4.51M
-70.07%727.00K
-84.54%439.00K
+752.71%842.00K
+158.14%1.57M
+209.71%2.43M
+328.48%2.84M
+89.29%-129.00K
-89.04%-2.69M
-46.43%-2.21M
+23.41%-1.24M
+27.63%-1.21M
+14.93%-1.42M
+8.42%-1.51M
+1.46%-1.62M
+0.12%-1.67M
+2.67%-1.67M
+3.39%-1.65M
+1.79%-1.65M
Non-Operating Interest Income
+58.13%6.05M
+57.20%7.34M
-34.04%3.73M
-42.76%3.46M
-2.45%3.83M
+220.15%4.67M
+366.42%5.65M
+706.95%6.04M
+596.63%3.92M
+244.92%1.46M
+325.26%1.21M
+924.66%748.00K
+3027.78%563.00K
+6950.00%423.00K
+3971.43%285.00K
+812.50%73.00K
+50.00%18.00K
+0.00%6.00K
+16.67%7.00K
-52.94%8.00K
Non-Operating Interest Expense
-6.94%2.78M
-8.82%2.83M
-6.89%3.00M
-5.63%3.02M
-26.34%2.98M
-25.17%3.11M
-5.90%3.22M
+60.52%3.20M
+129.13%4.05M
+124.74%4.15M
+90.65%3.43M
+17.39%1.99M
+5.05%1.77M
+9.94%1.85M
+8.38%1.80M
+2.48%1.70M
+0.24%1.68M
-2.67%1.68M
-3.32%1.66M
-2.30%1.66M
Other Income (Expense)
+248.77%1.46M
-4.49%595.00K
-120.45%-1.45M
+79.78%-612.00K
+97.05%-978.00K
+109.62%623.00K
-66.16%7.08M
-367.64%-3.03M
-404.30%-33.10M
-223.56%-6.48M
+1947.35%20.91M
-59.21%1.13M
-194.36%-6.56M
-66.97%5.24M
-104.75%-1.13M
-79.30%2.77M
-72.19%6.96M
+122.82%15.87M
+532.11%23.84M
+178.77%13.40M
Gain on Sale of Security
+248.77%1.46M
-4.49%595.00K
-120.45%-1.45M
+78.82%-641.00K
+81.02%-978.00K
+109.62%623.00K
+5.27%7.08M
-367.64%-3.03M
+21.50%-5.15M
-223.56%-6.48M
+693.29%6.72M
-59.21%1.13M
-194.32%-6.56M
-66.97%5.24M
-104.75%-1.13M
-79.30%2.77M
-72.19%6.96M
+122.82%15.87M
+532.11%23.84M
+178.77%13.40M
Special Income (Charges)
----
---29.00K
--0.00
--29.00K
+100.00%0.00
--0.00
-100.00%0.00
--0.00
---27.95M
--0.00
--14.19M
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
-Less:Other Special Charges
----
----
----
----
----
--0.00
----
----
--27.95M
--0.00
---14.19M
----
----
----
----
----
----
----
----
----
-Gain on Sale of Property/Plant/Equipment
----
----
--0.00
--29.00K
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
Other Non-Operating Income (Expenses)
----
----
----
----
----
----
----
----
----
--0.00
----
----
+50.00%-1.00K
--0.00
--1.00K
----
---2.00K
----
----
--1.00K
Pretax Profit
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
+1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
+97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
+95.50%-3.85M
+122.25%2.66M
+76.81%-8.48M
Net Profit
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
+1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
+97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
+95.50%-3.85M
+122.25%2.66M
+76.81%-8.48M
Profit from Continuing Operations
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
+1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
+97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
+95.50%-3.85M
+122.25%2.66M
+76.81%-8.48M
Net Income to Parent Company
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
+1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
+97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
+95.50%-3.85M
+122.25%2.66M
+76.81%-8.48M
Net Income to Common Stockholders
-38.34%-88.61M
-33.62%-64.65M
-90.22%-69.42M
-54.91%-67.81M
+1.23%-64.05M
-65.60%-48.39M
-6972.29%-36.49M
-111.67%-43.78M
-113.89%-64.85M
-88.01%-29.22M
+97.87%-516.00K
-10.21%-20.68M
-141.73%-30.32M
-303.69%-15.54M
-1010.35%-24.19M
-121.27%-18.77M
-501.86%-12.54M
+95.50%-3.85M
+122.25%2.66M
+76.81%-8.48M
Basic EPS
-5.26%-0.40
+0.00%-0.29
-72.73%-0.38
-50.00%-0.39
+22.45%-0.38
+17.14%-0.29
-2100.00%-0.22
+0.00%-0.26
-25.64%-0.49
-75.00%-0.35
+96.77%-0.01
-8.33%-0.26
-143.75%-0.39
-300.00%-0.20
-1133.33%-0.31
-118.18%-0.24
-500.00%-0.16
+95.87%-0.05
+115.79%0.03
+82.81%-0.11
Diluted EPS
-5.26%-0.40
+0.00%-0.29
-72.73%-0.38
-50.00%-0.39
+22.45%-0.38
+17.14%-0.29
+12.00%-0.22
+0.00%-0.26
-25.64%-0.49
-45.83%-0.35
+19.35%-0.25
-4.00%-0.26
-77.27%-0.39
-4.35%-0.24
-34.78%-0.31
+0.00%-0.25
+8.33%-0.22
+80.99%-0.23
-9.52%-0.23
+60.94%-0.25
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q32021/Q2
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military Show More